SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-24-050908
Filing Date
2024-02-28
Accepted
2024-02-28 17:16:26
Documents
114
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d723690d10k.htm   iXBRL 10-K 2206984
2 EX-10.1(A) d723690dex101a.htm EX-10.1(A) 16075
3 EX-10.1(B) d723690dex101b.htm EX-10.1(B) 15653
4 EX-10.1(C) d723690dex101c.htm EX-10.1(C) 52226
5 EX-10.1(D) d723690dex101d.htm EX-10.1(D) 53783
6 EX-10.4 d723690dex104.htm EX-10.4 30802
7 EX-23.1 d723690dex231.htm EX-23.1 1933
8 EX-31.1 d723690dex311.htm EX-31.1 10412
9 EX-31.2 d723690dex312.htm EX-31.2 10427
10 EX-32.1 d723690dex321.htm EX-32.1 3772
11 EX-32.2 d723690dex322.htm EX-32.2 3715
12 EX-97.1 d723690dex971.htm EX-97.1 21341
18 GRAPHIC g723690g0216042347602.jpg GRAPHIC 6484
19 GRAPHIC g723690g0216043646046.jpg GRAPHIC 6484
20 GRAPHIC g723690g0217024458003.jpg GRAPHIC 22805
  Complete submission text file 0001193125-24-050908.txt   10104177

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA cprx-20231231.xsd EX-101.SCH 77811
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20231231_cal.xml EX-101.CAL 66106
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20231231_def.xml EX-101.DEF 281293
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20231231_lab.xml EX-101.LAB 550619
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20231231_pre.xml EX-101.PRE 472326
116 EXTRACTED XBRL INSTANCE DOCUMENT d723690d10k_htm.xml XML 1676073
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33057 | Film No.: 24696900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)